Safety and clinical efficacy of invasive treatment for portal vein thrombosis after splenectomy or devascularization
10.3760/cma.j.cn113855-20220225-00109
- VernacularTitle:脾切除断流或断流术后门静脉血栓形成有创治疗的安全性与临床疗效分析
- Author:
Yifan WU
1
;
Ting CUI
;
Zhendong YUE
;
Lei WANG
;
Zhenhua FAN
;
Yu ZHANG
;
Xiuqi WANG
;
Zhiwei LI
;
Ruizhao QI
;
Fuquan LIU
Author Information
1. 首都医科大学附属北京世纪坛医院介入治疗科,北京 100038
- Keywords:
Venous thrombosis;
Hypertension, portal;
Splenectomy;
Devascularization
- From:
Chinese Journal of General Surgery
2022;37(6):420-424
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the safety and clinical efficacy of invasive treatment for portal vein thrombosis after splenectomy or devascularization.Methods:Invasive treatment was retrospectively analyzed from Jan 2016 to Jan 2020. In 319 cases who met the inclusion criteria.Result:There were complications in 41 cases and no death;The average portal vein pressure before and after thrombus clearance treatment was (25.6±4.9) mmHg and (14.7±4.1) mmHg respectively ( t=2.53, P<0.05); Thrombus decreased significantly in most patients. Conclusion:Invasive therapy is a safe and effective method for patients complicated with portal vein thrombosis after splenectomy or devascularization.
